Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

CRGX

CARGO Therapeutics Inc

Jun 14 • 04:00PM ET

16.72

Dollar change -0.46
Percentage change -2.68	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM XBI VXF IWN SCHA VTWO IWO IWC PTH

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-	Insider Own	33.28%	Shs Outstand	41.21M	Perf Week	-6.90%
Market Cap	658.43M	Forward P/E	-	EPS next Y	-5.30	Insider Trans	2.29%	Shs Float	26.27M	Perf Month	-20.34%
Income	-	PEG	-	EPS next Q	-1.12	Inst Own	72.26%	Short Float	13.18%	Perf Quarter	-46.55%
Sales	-	P/S	-	EPS this Y	70.84%	Inst Trans	-	Short Ratio	13.03	Perf Half Y	9.00%
Book/sh	9.48	P/B	1.76	EPS next Y	-9.96%	ROA	-	Short Interest	3.46M	Perf Year	-
Cash/sh	9.55	P/C	1.75	EPS next 5Y	-	ROE	-	52W Range	13.14 - 33.92	Perf YTD	-27.78%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-50.71%	Beta	-
Dividend TTM	-	Quick Ratio	16.78	Sales past 5Y	0.00%	Gross Margin	-	52W Low	27.25%	ATR (14)	1.31
Dividend Ex-Date	-	Current Ratio	16.78	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	32.97	Volatility	6.11% 7.41%
Employees	-	Debt/Eq	0.08	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	31.33
Option/Short	No / Yes	LT Debt/Eq	0.07	EPS Q/Q	-193.02%	Payout	-	Rel Volume	0.76	Prev Close	17.18
Sales Surprise	-	EPS Surprise	17.40%	Sales Q/Q	-	Earnings	May 14 AMC	Avg Volume	265.74K	Price	16.72
SMA20	-12.11%	SMA50	-14.64%	SMA200	-19.41%	Trades		Volume	201,372	Change	-2.68%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-23	Initiated	Truist	Buy	$34
Dec-05-23	Initiated	TD Cowen	Outperform
Dec-05-23	Initiated	JP Morgan	Overweight	$23
Dec-05-23	Initiated	Jefferies	Buy	$28

Jun-04-24 04:05PM	CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director (GlobeNewswire)
01:56PM	Hedge Fund and Insider Trading News: Bill Ackman, Jim Chanos, Daniel Loeb, Mark Yusko, Citadel LLC, CARGO Therapeutics Inc (CRGX), Apple Inc. (AAPL), and More (Insider Monkey)
May-30-24 06:00AM	Undiscovered Stocks on the Verge of a Breakout: 3 Names to Know Now (InvestorPlace)
May-28-24 08:05AM	CARGO Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) -14.33%
08:00AM	CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing (GlobeNewswire)
12:00PM	Loading…
May-22-24 12:00PM	What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock (Zacks)
09:55AM	Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High? (Zacks)
May-14-24 09:54PM	CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
04:05PM	CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-15-24 04:05PM	CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors (GlobeNewswire)
Mar-21-24 10:53PM	CRGX Stock Earnings: Cargo Therapeutics Misses EPS for Q4 2023 (InvestorPlace) -6.23%
04:05PM	CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-29-24 04:01PM	CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference (GlobeNewswire)
Jan-03-24 08:05AM	CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -11.58%
Dec-18-23 04:04PM	Alexandria Snags a Pair of Big Bicoastal Lab Leases (Commercial Observer)
10:51PM	Loading…
Dec-13-23 10:51PM	CRGX Stock Earnings: Cargo Therapeutics Reported Results for Q3 2023 (InvestorPlace)
04:05PM	CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results (GlobeNewswire)
Dec-11-23 07:53PM	3 New Stock Listings That Can Deliver Multibagger Returns (InvestorPlace) -5.55%

Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Samsara BioCapital GP, LLC	10% Owner	May 30 '24	Buy	17.00	294,000	4,998,000	4,415,689	Jun 03 09:45 PM
Third Rock Ventures V, L.P.	10% Owner	Nov 14 '23	Buy	15.00	1,333,333	19,999,995	1,807,119	Nov 14 07:08 PM
PERCEPTIVE ADVISORS LLC	Former 10% Owner	Nov 14 '23	Buy	15.00	666,666	9,999,990	2,912,835	Nov 14 04:32 PM
Samsara BioCapital GP, LLC	10% Owner	Nov 14 '23	Buy	15.00	666,666	9,999,990	4,121,689	Nov 16 07:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRGX

CARGO Therapeutics Inc

Upgrade your FINVIZ experience